newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference

WATERTOWN, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR® platform to develop tolerogenic therapies that selectively mitigate unwanted immune respo